AstraZeneca US is a biopharmaceutical company focused on developing and delivering life-changing medicines. The company's main offerings include innovative treatments for a range of conditions, including oncolog
AstraZeneca is a global, innovation-driven biopharmaceutical business that discovers, develops, and commercializes prescription medicines. Its primary focus areas are cardiovascular, renal, and metabolic diseases, oncology, respiratory diseases, inflammation and autoimmunity, infection and vaccines, and neurosci...
astrazeneca has a deep-rooted heritage in oncology and offers a quickly growing portfolio of medicines with the potential to transform patients' lives. by following the science and championing the development of personalised combinations, astrazeneca is working to redefine cancer treatment and one...
Sanofi (NYSE:SNY) is a healthcare company. It focuses on pharmaceuticals and vaccines. It offers a range of life-saving vaccines and therapeutic treatments for conditions in immunology, oncology, neurology, rare blood disorders, and rare diseases, as well as consumer healthcare products. Its prod...
AstraZeneca discovers, develops, and commercializes prescription medicines in oncology and biopharmaceuticals, including in cardiovascular, respiratory, and immunology fields. AstraZeneca has a mission to analyze 2 million genomes/exomes by 2026 for integration with clinical data and use in research and ...
AstraZeneca is a global, innovation-driven biopharmaceutical business that discovers, develops, and commercializes prescription medicines. Its primary focus areas are cardiovascular, renal, and metabolic diseases, oncology, respiratory diseases, inflammation and autoimmunity, infection and vaccines, and neurosci...
Products and Services ProductsBrands Oncology: Calquence Acalabrutinib Enhertu Trastuzumab Deruxtecan Faslodex XYZ XYZ XYZ XYZ XYZ XYZ Understand AstraZeneca Plc portfolio and identify potential areas for collaboration Register your interest History History section provides information on new products, ...
We invest in distinctive science in three main therapy areas where we can make the most meaningful difference: oncology; cardiovascular and metabolic disease; and respiratory, inflammation and autoimmunity. As a global, innovation-driven pharmaceutical company that spans discovery, development, ...
AstraZeneca Oncology R&D executive vice-president Susan Galbraith said: “There is a continued need for new options and better outcomes for patients with HER2-positive metastatic breast cancer who often experience disease progression after initial treatment with available standards of care. ...
But of course, the liability for some of our products, and I will hand over in a second to Dave regarding the onco -- the oral oncology products, we will see a certain impact. But when we will give the guidance in the beginning of 2025, that will be part of the way we ...